Logo image of XRX

XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:XRX - US98421M1062 - Common Stock

2.72 USD
+0.03 (+1.12%)
Last: 1/16/2026, 8:00:02 PM
2.73 USD
+0.01 (+0.37%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, XRX scores 3 out of 10 in our fundamental rating. XRX was compared to 35 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX may be in some trouble as it scores bad on both profitability and health. XRX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • XRX had negative earnings in the past year.
  • XRX had a positive operating cash flow in the past year.
  • XRX had negative earnings in 4 of the past 5 years.
  • Each year in the past 5 years XRX had a positive operating cash flow.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

  • XRX has a Return On Assets (-9.84%) which is comparable to the rest of the industry.
  • The Return On Equity of XRX (-171.16%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -9.84%
ROE -171.16%
ROIC N/A
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

  • In the last couple of years the Operating Margin of XRX has declined.
  • Looking at the Gross Margin, with a value of 27.61%, XRX is in line with its industry, outperforming 45.71% of the companies in the same industry.
  • In the last couple of years the Gross Margin of XRX has declined.
  • The Profit Margin and Operating Margin are not available for XRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.61%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

  • XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, XRX has more shares outstanding
  • The number of shares outstanding for XRX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, XRX has a worse debt to assets ratio.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.05, we must say that XRX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.05, XRX perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
  • XRX has a debt to FCF ratio of 15.57. This is a negative value and a sign of low solvency as XRX would need 15.57 years to pay back of all of its debts.
  • XRX has a Debt to FCF ratio of 15.57. This is comparable to the rest of the industry: XRX outperforms 54.29% of its industry peers.
  • A Debt/Equity ratio of 7.00 is on the high side and indicates that XRX has dependencies on debt financing.
  • The Debt to Equity ratio of XRX (7.00) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 7
Debt/FCF 15.57
Altman-Z 1.05
ROIC/WACCN/A
WACC5.62%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • XRX has a Current Ratio of 1.10. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
  • XRX has a Current ratio of 1.10. This is comparable to the rest of the industry: XRX outperforms 45.71% of its industry peers.
  • XRX has a Quick Ratio of 1.10. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.77, XRX is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.77
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • The earnings per share for XRX have decreased strongly by -113.59% in the last year.
  • XRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.94% yearly.
  • XRX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
  • XRX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.26% yearly.
EPS 1Y (TTM)-113.59%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-20%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%28.34%

3.2 Future

  • Based on estimates for the next years, XRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.77% on average per year.
  • The Revenue is expected to decrease by -0.46% on average over the next years.
EPS Next Y-59.39%
EPS Next 2Y11.72%
EPS Next 3Y8.77%
EPS Next 5YN/A
Revenue Next Year11.91%
Revenue Next 2Y10.09%
Revenue Next 3Y5.67%
Revenue Next 5Y-0.46%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

  • XRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 2.27 indicates a rather cheap valuation of XRX.
  • Based on the Price/Forward Earnings ratio, XRX is valued cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (24.26), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.27
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, XRX is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
  • 100.00% of the companies in the same industry are more expensive than XRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.23
EV/EBITDA 17.36
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.72%
EPS Next 3Y8.77%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.97%, XRX has a reasonable but not impressive dividend return.
  • XRX's Dividend Yield is rather good when compared to the industry average which is at 0.64. XRX pays more dividend than 97.14% of the companies in the same industry.
  • XRX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

  • The dividend of XRX has a limited annual growth rate of 0.72%.
  • XRX has paid a dividend for at least 10 years, which is a reliable track record.
  • XRX has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.72%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • The earnings of XRX are negative and hence is the payout ratio. XRX will probably not be able to sustain this dividend level.
  • The dividend of XRX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-9.99%
EPS Next 2Y11.72%
EPS Next 3Y8.77%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

XEROX HOLDINGS CORP

NASDAQ:XRX (1/16/2026, 8:00:02 PM)

After market: 2.73 +0.01 (+0.37%)

2.72

+0.03 (+1.12%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)10-30
Earnings (Next)01-29
Inst Owners81.7%
Inst Owner Change0.01%
Ins Owners7.6%
Ins Owner Change-0.13%
Market Cap348.27M
Revenue(TTM)6.61B
Net Income(TTM)-991.00M
Analysts46
Price Target4.25 (56.25%)
Short Float %23.24%
Short Ratio6.84
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend1.14
Dividend Growth(5Y)0.72%
DP-9.99%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-416.19%
Min EPS beat(2)-892.08%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-240.68%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-143.49%
EPS beat(12)5
Avg EPS beat(12)-67.93%
EPS beat(16)7
Avg EPS beat(16)-62.02%
Revenue beat(2)1
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-2.56%
Revenue beat(12)3
Avg Revenue beat(12)-2.15%
Revenue beat(16)4
Avg Revenue beat(16)-1.97%
PT rev (1m)0%
PT rev (3m)-4.27%
EPS NQ rev (1m)8.07%
EPS NQ rev (3m)11.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.27
P/S 0.05
P/FCF 1.23
P/OCF 0.95
P/B 0.6
P/tB N/A
EV/EBITDA 17.36
EPS(TTM)-0.14
EYN/A
EPS(NY)1.2
Fwd EY44.05%
FCF(TTM)2.21
FCFY81.26%
OCF(TTM)2.87
OCFY105.38%
SpS51.6
BVpS4.52
TBVpS-19.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.84%
ROE -171.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.61%
FCFM 4.28%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.38%
ROCE(5y)3.56%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 7
Debt/FCF 15.57
Debt/EBITDA 16.47
Cap/Depr 26.17%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion 149.19%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.77
Altman-Z 1.05
F-Score4
WACC5.62%
ROIC/WACCN/A
Cap/Depr(3y)17.3%
Cap/Depr(5y)18.56%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.59%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-20%
EPS Next Y-59.39%
EPS Next 2Y11.72%
EPS Next 3Y8.77%
EPS Next 5YN/A
Revenue 1Y (TTM)3.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%28.34%
Revenue Next Year11.91%
Revenue Next 2Y10.09%
Revenue Next 3Y5.67%
Revenue Next 5Y-0.46%
EBIT growth 1Y-135.71%
EBIT growth 3Y-23.42%
EBIT growth 5Y-32.65%
EBIT Next Year74.94%
EBIT Next 3Y38.68%
EBIT Next 5Y20.31%
FCF growth 1Y-35.39%
FCF growth 3Y-5.93%
FCF growth 5Y-18.11%
OCF growth 1Y-24.02%
OCF growth 3Y-6.69%
OCF growth 5Y-17.45%

XEROX HOLDINGS CORP / XRX FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


Can you provide the valuation status for XEROX HOLDINGS CORP?

ChartMill assigns a valuation rating of 5 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


What is the profitability of XRX stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


What is the expected EPS growth for XEROX HOLDINGS CORP (XRX) stock?

The Earnings per Share (EPS) of XEROX HOLDINGS CORP (XRX) is expected to decline by -59.39% in the next year.